By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

Euthanasia protocols rely on off-label drugs. With little data and no oversight on complications, how do we know the death is ...

Sandisk's data center revenue surged and margins expanded as AI storage demand outpaces supply. Click here to read an ...

As AI systems move into real-world scale, leaders at the Mint Sovereign AI Summit examined what trust, governance and ...

Individuals with early antenatal prediabetes face a markedly higher risk for postpartum type 2 diabetes than those with ...

HECM mortgage-backed securities issuance hit $563M in January, up from December, but HECM endorsements fell 13.1% year over ...

A searchable database now contains documents from cases against Epstein and Ghislaine Maxwell, along with FBI investigations ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...

Salesforce is undervalued with a Buy rating justified by strong AI-driven growth catalysts and holistic solutions. Click here ...

To initially fit the bears with the collar cams, the researchers tracked them through the snow by helicopter last May.

At a recent roundtable with legal, risk, and audit leaders from India's top enterprises, a consistent concern emerged: AI adoption is accelerating faster than a ...

The FDA approved Scancell's phase 3 trial of iSCIB1+ for advanced melanoma, focusing on progression-free survival as a ...